Latest Tumors Stories

BERGISCH-GLADBACH, Germany, April 19, 2013 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) and Paul Scherrer Institute (PSI) are announcing a collaboration to further advance motion management techniques for proton therapy. The multi-year agreement, aimed at optimizing treatment strategies for indications such as cancer in the lung, liver, pancreas and breast, will evaluate strategies using a 4-D treatment planning simulator developed by PSI. Proton therapy involves the use of...

Researchers with the Institute of Urologic Oncology and the Department of Urology at UCLA have classified kidney cancer into several unique subtypes, a finding that will help physicians tailor treatment to individual patients and that moves cancer care one step closer to personalized medicine. The finding is the result of 10 years of UCLA researchers studying kidney cancers at the genetic and molecular levels, conducting chromosomal analyses in an effort to identify what mutations may be...

New minimally invasive therapy safely treats complex cancers, leaves healthy tissues intact A new, minimally invasive treatment that tears microscopic holes in tumors without harming healthy tissue is a promising treatment for challenging cancers, suggests a preliminary study being presented at the Society of Interventional Radiology's 38th Annual Scientific Meeting in New Orleans. "Irreversible electroporation (or IRE) is a new way to attack cancer, using microsecond electrical pulses...

The St. Jude Children's Research Hospital -- Washington University Pediatric Cancer Genome Project advances understanding of genetic defects underlying childhood low-grade gliomas and identifies promising new drug therapies The St. Jude Children's Research Hospital – Washington University Pediatric Cancer Genome Project has identified mutations responsible for more than half of a subtype of childhood brain tumor that takes a high toll on patients. Researchers also found evidence the...

A herpes virus infection may cause primary tumors of the heart in adults. polyDNA recommends killing the herpes virus as early as possible. Rochester, NY (PRWEB) April 14, 2013 Herpes is usually associated with genital sores, fever blisters, cold sores, sexually transmitted infections and social stigmas. However, a new study links both genital herpes and oral herpes to the development of tumors of the heart. “This study has shown that HSV DNA is detected significantly more frequently...

The St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project advances understanding of genetic defects underlying childhood low-grade gliomas and identifies promising new drug therapies MEMPHIS, Tenn., April 14, 2013 /PRNewswire-USNewswire/ -- The St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project has identified mutations responsible for more than half of a subtype of childhood brain tumor that takes a...

New minimally invasive therapy safely treats complex cancers, leaves healthy tissues intact NEW ORLEANS, April 14, 2013 /PRNewswire-USNewswire/ -- Highlights Minimally invasive electrical pulse treatment pokes microscopic holes in cancerous tumors without hurting healthy nearby tissue, research suggests. IRE appears to be beneficial in treating pancreatic, liver, lung and other challenging cancers, according to a study being presented at SIR 2013. While surgery and other...

Is the era of targeted therapy for breast cancer at hand? It could be, said experts at the Lester and Sue Smith Breast Center at Baylor College of Medicine – at least for a certain population of women. In a report that appears online today in the Journal of Clinical Oncology, the researchers have shown that a subset of breast cancer patients who have tumors overexpressing a protein called the human epidermal growth factor receptor 2 (HER-2 positive) may benefit from a combination of...

A new blood test revealed more of the gene mutations that sustain certain digestive-tract tumors than did a DNA analysis of a traditional tumor biopsy, Dana-Farber Cancer Institute investigators will report at a special symposium of the American Association for Cancer Research annual meeting in Washington, April 6-10. The findings (Abstract LB-295) will be released at a press conference on Saturday, April 6, 3:00 p.m. ET, and later at an oral presentation on Tuesday, April 9, 3:35 – 3:50...

Vanderbilt University Although bladder cancer is the sixth most common form of cancer in the U.S. and the most expensive to treat, the basic method that doctors use to treat it hasn’t changed much in more than 70 years. An interdisciplinary collaboration of engineers and doctors at Vanderbilt and Columbia Universities intends to change that situation dramatically. Headed by Nabil Simaan, associate professor of mechanical engineering at Vanderbilt, the team has developed a prototype...